Literature DB >> 15764699

PTEN as an effector in the signaling of antimigratory G protein-coupled receptor.

Teresa Sanchez1, Shobha Thangada, Ming-Tao Wu, Christopher D Kontos, Dianqing Wu, Hong Wu, Timothy Hla.   

Abstract

PTEN, a tumor suppressor phosphatase, is important in the regulation of cell migration and invasion. Physiological regulation of PTEN (phosphatase and tensin homolog deleted on chromosome 10) by cell surface receptors has not been described. Here, we show that the bioactive lipid sphingosine 1-phosphate (S1P), which acts through the S1P2 receptor (S1P2R) G protein-coupled receptor (GPCR) to inhibit cell migration, utilizes PTEN as a signaling intermediate. S1P2R inhibition of cell migration is abrogated by dominant-negative PTEN expression. S1P was unable to efficiently inhibit the migration of Pten(DeltaloxP/DeltaloxP) mouse embryonic fibroblasts; however, the antimigratory effect was restored upon the expression of PTEN. S1P2R activation of Rho GTPase is not affected in Pten(DeltaloxP/DeltaloxP) cells, and dominant-negative Rho GTPase reversed S1P inhibition of cell migration in WT cells but not in Pten(DeltaloxP/DeltaloxP) cells, suggesting that PTEN acts downstream of the Rho GTPase. Ligand activation of the S1P2R receptor stimulated the coimmunoprecipitation of S1P2R and PTEN. Interestingly, S1P2R signaling increased PTEN phosphatase activity in membrane fractions. Furthermore, tyrosine phosphorylation of PTEN was stimulated by S1P2R signaling. These data suggest that the S1P2R receptor actively regulates the PTEN phosphatase by a Rho GTPase-dependent pathway to inhibit cell migration. GPCR regulation of PTEN maybe a general mechanism in signaling events of cell migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764699      PMCID: PMC555509          DOI: 10.1073/pnas.0409784102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.

Authors:  F Vazquez; S R Grossman; Y Takahashi; M V Rokas; N Nakamura; W R Sellers
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

2.  Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins.

Authors:  J H Paik; M J Lee; S Thangada; T Hla
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

3.  Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.

Authors:  E M Schmelz; P C Roberts; E M Kustin; L A Lemonnier; M C Sullards; D L Dillehay; A H Merrill
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

Review 4.  Lysophospholipids--receptor revelations.

Authors:  T Hla; M J Lee; N Ancellin; J H Paik; M J Kluk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

5.  Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Authors:  J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

6.  Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity.

Authors:  Eric S White; Rachelle G Atrasz; Emily G Dickie; David M Aronoff; Vuk Stambolic; Tak W Mak; Bethany B Moore; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2004-11-11       Impact factor: 6.914

7.  Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells.

Authors:  J P Gratton; M Morales-Ruiz; Y Kureishi; D Fulton; K Walsh; W C Sessa
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

8.  Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis.

Authors:  M J Lee; S Thangada; J H Paik; G P Sapkota; N Ancellin; S S Chae; M Wu; M Morales-Ruiz; W C Sessa; D R Alessi; T Hla
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

9.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

Authors:  Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

10.  Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.

Authors:  X Wu; K Hepner; S Castelino-Prabhu; D Do; M B Kaye; X J Yuan; J Wood; C Ross; C L Sawyers; Y E Whang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

View more
  81 in total

1.  In vitro effects of direct current electric fields on adipose-derived stromal cells.

Authors:  Kyle E Hammerick; Michael T Longaker; Fritz B Prinz
Journal:  Biochem Biophys Res Commun       Date:  2010-05-07       Impact factor: 3.575

Review 2.  Emerging mechanisms of neutrophil recruitment across endothelium.

Authors:  Marcie R Williams; Verónica Azcutia; Gail Newton; Pilar Alcaide; Francis W Luscinskas
Journal:  Trends Immunol       Date:  2011-08-11       Impact factor: 16.687

Review 3.  Big roles for small GTPases in the control of directed cell movement.

Authors:  Pascale G Charest; Richard A Firtel
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

4.  Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane.

Authors:  Francisca Vazquez; Satomi Matsuoka; William R Sellers; Toshio Yanagida; Masahiro Ueda; Peter N Devreotes
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

Review 5.  Regulation of vascular physiology and pathology by the S1P2 receptor subtype.

Authors:  Athanasia Skoura; Timothy Hla
Journal:  Cardiovasc Res       Date:  2009-03-15       Impact factor: 10.787

Review 6.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

7.  Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.

Authors:  Barry S Shea; Sarah F Brooks; Benjamin A Fontaine; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

8.  Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina.

Authors:  Athanasia Skoura; Teresa Sanchez; Kevin Claffey; Suzanne M Mandala; Richard L Proia; Timothy Hla
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.

Authors:  Lauren Bryan; Barbara S Paugh; Dmitri Kapitonov; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

10.  Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection.

Authors:  Dominic P Del Re; Shigeki Miyamoto; Joan Heller Brown
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.